OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 83 filers reported holding OVID THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,835,000 | -62.2% | 1,540,671 | -55.8% | 1.27% | -63.5% |
| Q2 2022 | $7,499,000 | -43.4% | 3,487,928 | -17.3% | 3.49% | -36.5% |
| Q1 2022 | $13,245,000 | +3.0% | 4,218,069 | +5.3% | 5.49% | -6.9% |
| Q4 2021 | $12,860,000 | +17.7% | 4,006,185 | +23.2% | 5.90% | +18.6% |
| Q3 2021 | $10,930,000 | +39.8% | 3,252,892 | +62.6% | 4.97% | +21.6% |
| Q2 2021 | $7,820,000 | -21.7% | 2,000,000 | -19.5% | 4.09% | -24.2% |
| Q1 2021 | $9,982,000 | – | 2,483,059 | – | 5.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,252,892 | $10,930,000 | 4.97% |
| GLOBEFLEX CAPITAL L P | 1,397,770 | $4,697,000 | 1.02% |
| BVF INC/IL | 6,631,051 | $22,280,000 | 0.87% |
| EcoR1 Capital, LLC | 6,082,200 | $20,436,000 | 0.71% |
| Ikarian Capital, LLC | 1,105,082 | $3,715,000 | 0.26% |
| CHI Advisors LLC | 233,510 | $785,000 | 0.23% |
| DCF Advisers, LLC | 141,701 | $476,000 | 0.21% |
| Artal Group S.A. | 2,500,000 | $8,400,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,577,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 1,903,162 | $6,394,000 | 0.02% |